Literature DB >> 20373459

Paired donor interchange to avoid ABO-incompatible living donor liver transplantation.

See Ching Chan1, Chung Mau Lo, Boon Hun Yong, Wilson J C Tsui, Kelvin K C Ng, Sheung Tat Fan.   

Abstract

We report an emergency paired donor interchange living donor liver transplant performed on January 13, 2009. The 4 operations (2 liver transplants) were performed simultaneously. The aim was to avoid 2 ABO-incompatible liver transplants. One recipient in acute liver failure underwent transplantation in a high-urgency situation. The abdomen of the other recipient had severe adhesions from previous spontaneous bacterial peritonitis that rendered the recipient operation almost impossible. The ethical and logistical issues are discussed. Approaches adopted in anticipation of potential adverse outcomes are explained in view of the higher donor and recipient mortality and morbidity rates in comparison with kidney transplantation. (c) 2010 AASLD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20373459     DOI: 10.1002/lt.21970

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  4 in total

1.  Evaluating the living donor: expansion by innovation.

Authors:  Chung-Mau Lo
Journal:  Hepatol Int       Date:  2016-02-26       Impact factor: 6.047

Review 2.  Kidney exchange transplantation current status, an update and future perspectives.

Authors:  Vivek B Kute; Narayan Prasad; Pankaj R Shah; Pranjal R Modi
Journal:  World J Transplant       Date:  2018-06-28

Review 3.  Expanding Indications for Liver Transplant: Tumor and Patient Factors.

Authors:  Kevin Ka-Wan Chu; Kelly Hiu-Ching Wong; Kenneth Siu-Ho Chok
Journal:  Gut Liver       Date:  2021-01-15       Impact factor: 4.519

4.  Expanding living donor liver transplantation: Report of first US living donor liver transplant chain.

Authors:  Hillary J Braun; Ana M Torres; Finesse Louie; Sandra D Weinberg; Sang-Mo Kang; Nancy L Ascher; John P Roberts
Journal:  Am J Transplant       Date:  2020-12-08       Impact factor: 8.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.